STARJEMZA
Live / Applied — Second extension granted (statement of use) (as of 30 May 2025)
What this means for you
Not registered yet, but its 18 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98140106
- Mark type
- Stylized text
- Filed
- 18 Aug 2023
- Published for opposition
- 30 Apr 2024
- Attorney of record
- Michelle E. Tochtrop
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune disorders, excluding chronic hand eczema; pharmaceutical preparations for the treatment of psoriasis, psoriatic arthritis, Crohn's disease or ulcerative colitis.
Owner
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
Prosecution history
- 18 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 May 2025 — SOU EXTENSION 2 GRANTED
- 30 May 2025 — SOU EXTENSION 2 FILED
- 30 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2024 — SOU EXTENSION 1 GRANTED
- 11 Dec 2024 — SOU EXTENSION 1 FILED
- 11 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Jun 2024 — POST PUBLICATION AMENDMENT - ENTERED
- 06 Jun 2024 — ASSIGNED TO PETITION STAFF